CAMTEK LTD (CAMT) Fundamental Analysis & Valuation

NASDAQ:CAMT • IL0010952641

152.55 USD
-8.8 (-5.45%)
At close: Mar 12, 2026
155.17 USD
+2.62 (+1.72%)
Pre-Market: 3/13/2026, 7:46:41 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CAMT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, CAMT scores 5 out of 10 in our fundamental rating. CAMT was compared to 115 industry peers in the Semiconductors & Semiconductor Equipment industry. CAMT has only an average score on both its financial health and profitability. CAMT shows excellent growth, but is valued quite expensive already. These ratings would make CAMT suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. CAMT Profitability Analysis

1.1 Basic Checks

  • In the past year CAMT was profitable.
  • In the past 5 years CAMT has always been profitable.
  • CAMT had a positive operating cash flow in 4 of the past 5 years.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • CAMT has a Return On Assets of 4.03%. This is in the better half of the industry: CAMT outperforms 61.74% of its industry peers.
  • The Return On Equity of CAMT (8.22%) is better than 68.70% of its industry peers.
  • CAMT has a better Return On Invested Capital (8.82%) than 78.26% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CAMT is in line with the industry average of 10.52%.
Industry RankSector Rank
ROA 4.03%
ROE 8.22%
ROIC 8.82%
ROA(3y)9.1%
ROA(5y)9.89%
ROE(3y)15.44%
ROE(5y)17.53%
ROIC(3y)9.34%
ROIC(5y)10.06%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • CAMT has a better Profit Margin (10.22%) than 66.09% of its industry peers.
  • CAMT's Profit Margin has declined in the last couple of years.
  • With an excellent Operating Margin value of 25.94%, CAMT belongs to the best of the industry, outperforming 83.48% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CAMT has grown nicely.
  • CAMT's Gross Margin of 50.56% is fine compared to the rest of the industry. CAMT outperforms 63.48% of its industry peers.
  • CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.94%
PM (TTM) 10.22%
GM 50.56%
OM growth 3Y0.71%
OM growth 5Y12.32%
PM growth 3Y-25.69%
PM growth 5Y-6.06%
GM growth 3Y0.5%
GM growth 5Y1.48%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CAMT Health Analysis

2.1 Basic Checks

  • CAMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CAMT has more shares outstanding than it did 1 year ago.
  • CAMT has more shares outstanding than it did 5 years ago.
  • CAMT has a worse debt/assets ratio than last year.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • CAMT has an Altman-Z score of 8.44. This indicates that CAMT is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 8.44, CAMT is doing good in the industry, outperforming 66.96% of the companies in the same industry.
  • CAMT has a Debt/Equity ratio of 0.84. This is a neutral value indicating CAMT is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CAMT (0.84) is worse than 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 8.44
ROIC/WACC0.72
WACC12.17%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • CAMT has a Current Ratio of 8.35. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
  • CAMT has a better Current ratio (8.35) than 87.83% of its industry peers.
  • A Quick Ratio of 7.31 indicates that CAMT has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 7.31, CAMT belongs to the best of the industry, outperforming 87.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.35
Quick Ratio 7.31
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. CAMT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 14.23% over the past year.
  • Measured over the past years, CAMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.06% on average per year.
  • CAMT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.65%.
  • The Revenue has been growing by 26.06% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
Revenue 1Y (TTM)15.65%
Revenue growth 3Y15.63%
Revenue growth 5Y26.06%
Sales Q2Q%9.23%

3.2 Future

  • CAMT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.41% yearly.
  • CAMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.80% yearly.
EPS Next Y8.89%
EPS Next 2Y16.72%
EPS Next 3Y16.49%
EPS Next 5Y19.41%
Revenue Next Year12.01%
Revenue Next 2Y15.26%
Revenue Next 3Y15.17%
Revenue Next 5Y16.8%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. CAMT Valuation Analysis

4.1 Price/Earnings Ratio

  • CAMT is valuated quite expensively with a Price/Earnings ratio of 47.52.
  • CAMT's Price/Earnings ratio is a bit cheaper when compared to the industry. CAMT is cheaper than 62.61% of the companies in the same industry.
  • CAMT is valuated expensively when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 43.64, the valuation of CAMT can be described as expensive.
  • CAMT's Price/Forward Earnings ratio is in line with the industry average.
  • CAMT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 47.52
Fwd PE 43.64
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of CAMT may justify a higher PE ratio.
  • CAMT's earnings are expected to grow with 16.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.35
PEG (5Y)1.25
EPS Next 2Y16.72%
EPS Next 3Y16.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CAMT Dividend Analysis

5.1 Amount

  • No dividends for CAMT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAMT Fundamentals: All Metrics, Ratios and Statistics

CAMTEK LTD

NASDAQ:CAMT (3/12/2026, 8:26:36 PM)

Premarket: 155.17 +2.62 (+1.72%)

152.55

-8.8 (-5.45%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-18
Earnings (Next)05-11
Inst Owners55.34%
Inst Owner Change-2.8%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap6.99B
Revenue(TTM)496.07M
Net Income(TTM)50.72M
Analysts81.11
Price Target177.31 (16.23%)
Short Float %11.05%
Short Ratio5.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.33
Dividend Growth(5Y)56.74%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.12%
Min EPS beat(2)-2.36%
Max EPS beat(2)0.11%
EPS beat(4)2
Avg EPS beat(4)-1%
Min EPS beat(4)-2.36%
Max EPS beat(4)0.51%
EPS beat(8)6
Avg EPS beat(8)1.58%
EPS beat(12)9
Avg EPS beat(12)2.04%
EPS beat(16)12
Avg EPS beat(16)1.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-0.59%
Revenue beat(8)2
Avg Revenue beat(8)-0.4%
Revenue beat(12)2
Avg Revenue beat(12)-0.58%
Revenue beat(16)2
Avg Revenue beat(16)-0.83%
PT rev (1m)26.5%
PT rev (3m)39.98%
EPS NQ rev (1m)-1.73%
EPS NQ rev (3m)-0.96%
EPS NY rev (1m)2.95%
EPS NY rev (3m)4.17%
Revenue NQ rev (1m)3.41%
Revenue NQ rev (3m)4.02%
Revenue NY rev (1m)5.56%
Revenue NY rev (3m)6.13%
Valuation
Industry RankSector Rank
PE 47.52
Fwd PE 43.64
P/S 14.09
P/FCF N/A
P/OCF N/A
P/B 11.33
P/tB 13.13
EV/EBITDA N/A
EPS(TTM)3.21
EY2.1%
EPS(NY)3.5
Fwd EY2.29%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.82
BVpS13.46
TBVpS11.62
PEG (NY)5.35
PEG (5Y)1.25
Graham Number31.18
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 8.22%
ROCE 11.17%
ROIC 8.82%
ROICexc 21%
ROICexgc 25.43%
OM 25.94%
PM (TTM) 10.22%
GM 50.56%
FCFM N/A
ROA(3y)9.1%
ROA(5y)9.89%
ROE(3y)15.44%
ROE(5y)17.53%
ROIC(3y)9.34%
ROIC(5y)10.06%
ROICexc(3y)18.07%
ROICexc(5y)29.31%
ROICexgc(3y)22.71%
ROICexgc(5y)32.19%
ROCE(3y)11.82%
ROCE(5y)12.73%
ROICexgc growth 3Y-9.39%
ROICexgc growth 5Y-5.81%
ROICexc growth 3Y-14.91%
ROICexc growth 5Y-9.14%
OM growth 3Y0.71%
OM growth 5Y12.32%
PM growth 3Y-25.69%
PM growth 5Y-6.06%
GM growth 3Y0.5%
GM growth 5Y1.48%
F-ScoreN/A
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.35
Quick Ratio 7.31
Altman-Z 8.44
F-ScoreN/A
WACC12.17%
ROIC/WACC0.72
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.23%
EPS 3Y19.52%
EPS 5Y38.06%
EPS Q2Q%5.19%
EPS Next Y8.89%
EPS Next 2Y16.72%
EPS Next 3Y16.49%
EPS Next 5Y19.41%
Revenue 1Y (TTM)15.65%
Revenue growth 3Y15.63%
Revenue growth 5Y26.06%
Sales Q2Q%9.23%
Revenue Next Year12.01%
Revenue Next 2Y15.26%
Revenue Next 3Y15.17%
Revenue Next 5Y16.8%
EBIT growth 1Y17.96%
EBIT growth 3Y16.45%
EBIT growth 5Y41.58%
EBIT Next Year10.23%
EBIT Next 3Y14.63%
EBIT Next 5Y16.51%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CAMTEK LTD / CAMT FAQ

What is the fundamental rating for CAMT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CAMT.


What is the valuation status of CAMTEK LTD (CAMT) stock?

ChartMill assigns a valuation rating of 2 / 10 to CAMTEK LTD (CAMT). This can be considered as Overvalued.


How profitable is CAMTEK LTD (CAMT) stock?

CAMTEK LTD (CAMT) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CAMT stock?

The Price/Earnings (PE) ratio for CAMTEK LTD (CAMT) is 47.52 and the Price/Book (PB) ratio is 11.33.


What is the financial health of CAMTEK LTD (CAMT) stock?

The financial health rating of CAMTEK LTD (CAMT) is 5 / 10.